For the latest news, weather, sports, and streaming video, head to The Hill.
Search terms included combinations of GLP-1 receptor agonist, semaglutide, liraglutide, tirzepatide, cutaneous side effects, dermatology, hidradenitis, psoriasis, bullous pemphigoid, facial aging, and plastic surgery. Of 260 articles initially identified, 155 were included on the basis of predefined eligibility criteria prioritizing randomized controlled trials, observational studies, systematic reviews, regulatory reports, and clinically relevant case series in adult populations
Additional pressure might come from MassHealth, which could also stop covering GLP-1 drugs in fiscal 2027
The fix is simple but requires discipline: pick a specific day and time each week and dose within 12 hours of that time, every week, for at least 6 weeks